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Visual biofeedback training reduces
quantitative drugs index scores associated
with fall risk
Eric Anson1, Elizabeth Thompson2, Samuel C. Karpen3, Brian L. Odle4, Edith Seier5, John Jeka6
and Peter C. Panus7*

Abstract
Objective: Drugs increase fall risk and decrease performance on balance and mobility tests. Conversely, whether
biofeedback training to reduce fall risk also decreases scores on a published drug-based fall risk index has not been
documented. Forty-eight community-dwelling older adults underwent either treadmill gait training plus visual feedback (+VFB), or walked on a treadmill without feedback. The Quantitative Drug Index (QDI) was derived from each
participant’s drug list and is based upon all cause drug-associated fall risk. Analysis of covariance assessed changes in
the QDI during the study, and data is presented as mean ± standard error of the mean.
Results: The QDI scores decreased significantly (p = 0.031) for participants receiving treadmill gait training +VFB
(− 0.259 ± 0.207), compared to participants who walked on the treadmill without VFB (0.463 ± 0.246). Changes in participants QDI scores were dependent in part upon their age, which was a significant covariate (p = 0.007). These preliminary results demonstrate that rehabilitation to reduce fall risk may also decrease use of drugs associated with falls.
Determination of which drugs or drug classes that contribute to the reduction in QDI scores for participants receiving
treadmill gait training +VFB, compared to treadmill walking only, will require a larger participant investigation.
Trial Registration ISRNCT01690611, ClinicalTrials.gov #366151-1, initial 9/24/2012, completed 4/21/2016
Keywords: Falls, Elderly, Polypharmacy, Biofeedback, Treadmill, Visual, Drug index, Community, Ambulatory, Covariate
Introduction
Polypharmacy is the clinical use of multiple drugs, and is
a predictor of falls in the elderly [1–3]. Performance on
mobility and balance tests decreases as the total number
of drugs, or the number of drugs associated with fall risk,
increases [3–6]. Additionally, reduction or elimination
of fall-risk drugs from patients’ pharmacotherapy regimen improves physical function and reduces falls [7, 8].
Various clinical tools attempt to quantify the relationship between fall risk and drugs. Of these, Beer’s list and
the Drug Burden Index are two of the most reported, yet
both have limitations [9, 10]. The former is a prescriptive
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guideline identifying drugs associated with adverse
effects in the elderly, but it does not quantitate drugmediated fall risk. The latter quantitates drug-mediated fall risk, but is limited to drugs with sedation and
anticholinergic adverse effects.
We developed a Quantitative Drug Index (QDI) that
expands the list of drug adverse effects associated with
fall risk [4]. The QDI is a clinically anchored index including all potential adverse effects associated with drugmediated fall risk. To date there are no studies examining
whether rehabilitation training to reduce falls influences
the reported use of drugs associated with fall risk. We
hypothesize that self-reported use of drugs associated
with fall risk would decrease in participants receiving
balance and mobility training on a treadmill while controlling trunk motion using visual feedback (+VFB),
compared to those walking on a treadmill alone. The
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present research is an extension of our previously published efforts examining the effects of the QDI on balance
and mobility testing [4].

Main text
Methods

This is a secondary analysis from a larger study examining the effects on balance and mobility of treadmill walking only, compared to treadmill gait training +VFB for
controlling trunk motion [11]. The original study and
this secondary analysis were approved by the institutional review boards at the University of Maryland, Temple University and East Tennessee State University. The
purpose of the original investigation was to determine
whether 4 weeks of treadmill gait training +VFB for controlling trunk motion would result in improved balance
for older adults with self-reported balance problems.
Participants were recruited for the study (ClinicalTrials.gov #366151-1) by advertisements in the newspaper
and flyers placed at local retirement communities from
2012 to 2015. A total of 61 participants were evaluated
for enrollment into the study. Eligibility criteria for the
study included passing the mini-mental state examination (MMSE) with a score of 24 or higher and the ability to walk independently on a treadmill at a self-selected
speed for 2 min [12]. The drug list information was provided by participants prior to and following the study
period. All drugs were assessed and a QDI score for each
participant’s drug list pre- and post-study calculated [4].
Differences between post- and pre-QDI scores were calculated for participants. Two participants were excluded
from the study as they were unable to walk independently
on the treadmill at a self-selected pace and one participant had an MMSE score of less than 24. A total of 58
consented participants were enrolled in the study. Six
subjects did not complete the study, and the drug lists for
four participants were not recorded, one at the beginning
and three at the end of the study. Thus, for these secondary analyses, data from 48 participants were used. Twenty
participants walked on a treadmill without VFB. Twentyeight participants received treadmill gait training +VFB,
with instructions to minimize trunk motion [11]. During
enrollment age, height, weight and number of reported
falls in the previous 12 months were recorded. Body Mass
Index (BMI) was calculated from height and weight information. BMI could not be calculated for one participant
in the treadmill only group as weight was not recorded
for that individual. All participants also completed the
activity-specific balance confidence (ABC) scale prior
to and at completion of the study [13]. Graphics, t-test,
analysis of covariance (ANCOVA), two way repeated
measures analysis of variance (ANOVA) and descriptive analyses were conducted using IBM SPSS Statistics
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22 (IBM Inc., Armonk, NY), or Slide Write (Advanced
Graphics Software, Encinitas, CA) [14]. The randomization test comparing the QDI score differences between
treadmill walking only and treadmill gait training +VFB
was written in R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria) [15]. The randomization test does
not assume normality of the dependent variable, and was
used to determine whether the t-test was biased by nonnormality. Significance was set at = 0.05 for all analyses,
and data presented as mean and standard error of the
mean. The drug lists with corresponding QDI scores, age,
MMSE scores, ABC scale scores, weight, height, reported
falls in the previous 12 months and intervention group
for all participants are in Additional file 1. The adverse
effects for the QDI scale are in the supplemental data
(Additional file 2: Appendix S1).
Results

Prior to the study there were no significant differences
between the treadmill walking only participants and
treadmill gait training +VFB participants for age, BMI or
number of reported falls within the previous 12 months
(Table 1). The MMSE scores for two groups were also
similar. The participants in the two groups at the beginning and end of the study recorded similar levels of balance confidence in performing various daily activities as
determined by the ABC scale scores (Table 1).
A t-test of the intervention period changes in QDI
scores between treadmill walking only (0.350 ± 0.386)
compared
to
treadmill
gait
training
+VFB
(− 0.179 ± 0.090) was not significant (p = 0.13). The
changes in QDI scores may have a non-normal distribution (Additional file 2: Appendix S2). To validate the
t-test, a randomization test was done as it is immune to
non-normality (Additional file 2: Appendix S3). The randomization test was also not significant (p = 0.14). As the
two tests produced similar nonsignificant p-values, the
t-test was assumed to be robust to non-normality. When
age is included as a covariate (p = 0.007) in an ANCOVA,
there was a significant difference (p = 0.031) for the
changes in QDI scores during the intervention period
when comparing treadmill walking only participants
to treadmill gait training +VFB participants (Table 2).
The average changes for the QDI score increased in the
treadmill walking only participants, and decreased in
the treadmill gait training +VFB participants. Finally,
the treadmill walking only participants demonstrated no
change, increased or decreased-QDI scores during the
training period, whereas the treadmill gait training +VFB
participants demonstrated either no change or decreased
QDI scores during this period (Fig. 1). The post-treatment minus pre-treatment QDI scores for the majority
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Table 1 Comparison of participant parameters, reported falls, mental status and fall risk scores for both treadmill
only participants and gait training +VFB participants
Variable

Age
BMI
MMSE
Falls
ABC scale

Pre-treatment scores

Post-treatment scores

p value

Treadmill only

Gait training +VFB

75.6 ± 1.56

78.4 ± 1.19

0.15

28.4 ± 0.28

28.4 ± 0.29

0.92

27.2 ± 1.14

Treadmill only

Gait training +VFB

27.1 ± 1.34

1.55 ± 0.71

0.94

1.14 ± 0.25

78.4 ± 3.58

0.59

75.0 ± 3.03

79.4 ± 4.09

75.0 ± 3.46

0.75

The sample size was N = 20 in the treadmill only group and N = 28 in the treadmill plus visual feedback (+VFB) group. One participant was lost for body mass index
(BMI) calculation in the treadmill only group (N = 19), as weight was not recorded for the participant. Falls were the number of reported falls by participants within
the previous 12 months. Two group T-test were conducted on the variables: age, body mass index (BMI), mini-mental status exam (MMSE) and reported falls in the
previous 12 months. A 2-WAY repeated measures analysis of variance was conducted on the variable activity specific balance confidence (ABC) scale

Table 2 Analysis of covariance for the change in QDI scores for treadmill walking only participants compared to treadmill
gait training +VFB participants
Group

N

Treadmill walking only

20

Treadmill gait training +VFB

28

Common average for age covariate

QDI scores change

0.463 ± 0.246

− 0.259 ± 0.207

ANCOVA

0.031

Age
covariate
(p value)
0.007
77.2

QDI Quantitative Drug Index, VFB visual biofeedback
Overall model was significant at p = 0.008. Change in QDI scores are post-scores minus pre-scores. Data is presented as mean and standard error of the mean.
The common regression function variables were intercept equals − 5.595 and the slope for the age was 0.069. The coefficient of determination for the model was
R2 = 0.194

of participants in both groups did not change during the
training interval, as demonstrated by the change in QDI
scores on the zero axis.
Discussion

Fig. 1 Scatterplot of the change in QDI scores for both the
treadmill walking only participants (open squares) and treadmill gait
training +VFB participants (open triangles), as a function of age.
The horizontal line (score of zero), represents no change between
the post- and pre- intervention QDI scores. The graph contains
replicate change in QDI scores for several specific ages, in both
treadmill walking only and treadmill gait training +VFB groups. These
replicates may result in each icon representing more than a single
response

A previous report indicated that withdrawal of participants’ fall-risk increasing drugs decreased subsequent
fall risk, but not in the participants without pharmacotherapy intervention [7]. Surprisingly, a reduction of high
fall risk cardiovascular drugs but not high fall risk psychotropic drugs significantly reduced subsequent falls.
Unfortunately, the investigation did not use a scaled
index for their drug-associated fall risk assessment,
so quantitation was impossible. As the QDI assesses
and quantifies fall risk associated with all adverse drug
effects, the QDI should be able to detect drug-associated
fall risk regardless of the pharmacologic mechanism [4].
In contrast, quantitative drug indices that do not assess
all fall risk drug-associated adverse effects may miss fall
risk associated with some drugs [5, 6, 9].

Anson et al. BMC Res Notes

(2018) 11:750

The current results demonstrate that participants in
the treadmill gait training +VFB reduced reported use
of fall-risk associated drugs compared to participants
only walking on a treadmill. These results are based on
a comparison of changes in QDI scores for both groups,
after adjusting for age. Visualization of the QDI change
score data demonstrates that several participants in the
treadmill gait training +VFB group decreased use of
drugs associated with fall risk, and no participant in this
group added a drug associated with fall risk. Additionally, participant parameters for the two groups such as
age and BMI were similar, as was mental status as determined by the MMSE scores. The number of reported
falls in the previous 12 months were also similar for the
two groups. The similarity in the number of reported
falls by participants in both groups is also supported by
similar self-reported balance confidence scores on typical
daily life mobility tasks both before and after the training intervention. In aggregate, these results suggest that
the two participant samples were similar based on measured physical, mental and mobility assessments. Thus, at
present the most probable cause for the decrease in QDI
scores, and use of fall-risk associated drugs, would be the
treadmill gait training with visual biofeedback intervention. No previous investigation has documented that fallrisk reduction training affects self-reported use of drugs
associated with fall risk.
Interestingly, the QDI scores for a number of participants in both groups remained unchanged during the
intervention period. Pharmacotherapeutic management
of the participants was not controlled during the study
limiting causal understanding of this phenomenon. However, at least two competing hypotheses support the current results. First, participants without any change in
QDI score may be more medically stable and thus less
likely to have a medical encounter resulting in altered
drug regimens. Thus the QDI would remain stable across
the intervention. Second, although none of the collected
participant characteristics differed between the groups
analyzed, there may in fact be an unmeasured participant
characteristic which would identify individuals more
likely to report change in drug use during rehabilitation.
The identification of participant characteristic(s) that
predict changes in pharmacotherapy during rehabilitation, especially a decrease, would be of significant clinical
value.
Conclusions

This is the first brief report documenting that treadmill gait training with visual biofeedback may lead to
decreased usage of fall-risk associated drugs. No other
measured variables associated with fall risk were significantly different between the two groups of participants
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that could have accounted for the changes in the QDI
scores during the study period. The mechanism(s) by
which the treadmill gait training plus visual biofeedback
mediates the decreased use of fall risk associated drugs
will require further investigation in a larger population.

Research limitations
There are several significant limitations to the current brief report. The sample size was small with only
48 participants. Additionally, only 12 out of 48 participants (25%) across both groups demonstrated a changes
in their QDI scores. A longer training period may have
increased this percentage. Only two time points were
assessed. Multiple follow-up time points may strengthen
the current results. However, pharmacotherapy for the
participants is likely to change continuously making the
validity of these additional time points questionable. The
sample size is also insufficient to identify specific drugs
or drug class(es) that resulted in the decrease in QDI
scores for the treadmill gait training +VFB participants.
Additional files
Additional file 1. Sheet 1: Mod Pre Med Data: includes a list of drugs for
participants prior to the study with Quantitative Drug Index (QDI) scores
under each drug. Total QDI score for each participant is in column AJ, and
total drug counts for each participant is in column AK. Sheet 2: Mod Post
Med Data: includes a list of drugs for participants at the end of the study
with Quantitative Drug Index (QDI) scores under each drug. Total QDI
score for each participant is in column AD, and total drug counts for each
participant is in column AE. Sheet 3: Pre & Post data: columns for each variable are as described: total pre-study QDI drug score (Mod Pre Drug Score)
for each participant, total post-study QDI drug score (Mod Post Drug
Score) for each participant, change in QDI scores (dQDI) post-intervention
minus pre-intervention, whether participants (Group) were in the control
arm (treadmill walking only—0) or the intervention arm (gait training plus
visual biofeedback—1); age, height, weight, participant stated number
of falls in the previous 12 months (fall 12 prev months), Mini-Mental State
Exam scores (MMSE), pre-study Activity Specific Balance Confidence scale
scores (Pre ABCscore) and post-study Activity Specific Balance Confidence
scale scores (Post ABCscore).
Additional file 2: Appendix S1. Table and Text of Quantitative Drug
Index adverse effects. Appendix S2. Figure and text documenting nonnormal distribution of QDI scores. Appendix S3. Figure of randomization
analysis and supporting text.
Abbreviations
ABC: activity-specific balance confidence; ANCOVA: analysis of covariance;
ANOVA: analysis of variance; BMI: body mass index; MMSE: mini-mental state
examination; QDI: Quantitative Drug Index; +VFB: plus visual feedback.
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